THNR ETF

$24.96
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing top 20 of 22 holdings— Unlock all holdings(as of Jan 30, 2026)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgSectorIndustry
1LLYEli Lilly & Co13.02%519$574.6K••••••••••••••••••••••
2NVO:CONovo Nordisk A/S ADR11.24%10,513$496.1K••••••••••••••••••••••
3AMGNAmgen Inc.7.36%887$324.8K••••••••••••••••••••••
4REGNRegeneron Pharmaceuticals, Inc.6.60%376$291.4K••••••••••••••••••••••
54519:JPChugai Pharmaceutical Co. Ltd. Com Stk6.54%5,200$288.8K••••••••••••••••••••••
64507:JPShionogi & Co Ltd5.90%12,100$260.5K••••••••••••••••••••••
7MRKMerck & Company Inc5.71%2,132$252.3K••••••••••••••••••••••
8ROG:SMRoche Holding Ag5.54%527$244.5K••••••••••••••••••••••
9PFEPfizer, Inc.4.97%8,199$219.6K••••••••••••••••••••••
10AZN:LNDeveloped Markets Astrazeneca Plc Sponsored Adr4.96%1,168$218.9K••••••••••••••••••••••
11ABBVAbbvie Inc4.62%940$204.1K••••••••••••••••••••••
121801:HKInnovent Biologics Inc4.44%19,000$196.1K••••••••••••••••••••••
131093:HKCSPC Pharmaceutical Group Limited Shs4.27%152,000$188.5K••••••••••••••••••••••
14ARWRArrowhead Pharmaceuticals Inc3.96%2,569$174.8K••••••••••••••••••••••
15HIMSHims & Hers Health Inc2.30%4,169$101.7K••••••••••••••••••••••
16ZEAL:COZealand Pharma As1.99%1,295$88.0K••••••••••••••••••••••
17SRRKScholar Rock Holding Corp1.71%1,615$75.6K••••••••••••••••••••••
18VKTXViking Therapeutics, Inc.1.50%2,236$66.1K••••••••••••••••••••••
19128940:KRHanmi Pharm Co Ltd1.04%123$45.8K••••••••••••••••••••••
20AGPXXInvesco Government & Agency Portfolio, Institutional Class0.88%38,694$38.7K••••••••••••••••••••••
2+ more holdings available
See all 22 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

THNR ETF All Holdings

THNR holdings total 22 positions. The top 10 holdings account for 71.8% of the fund, led by Eli Lilly & Co at 13.0%, Novo Nordisk A/S ADR at 11.2%, Amgen Inc. at 7.4%.

THNR portfolio concentration is relatively high, with the top 10 representing 71.8% of total assets. The largest sector exposure is Health Care at 76.7%.

THNR sector allocation provides a detailed breakdown. THNR overlap tool shows how holdings compare to other funds in your portfolio.

THNR ETF Holdings

22 of 22 holdings

  • 1

    Eli Lilly & Co

    LLYHealth Care
    13.02%
  • 2

    Novo Nordisk A/S ADR

    NVO:COHealth Care
    11.24%
  • 3

    Amgen Inc.

    AMGNHealth Care
    7.36%
  • 4

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    6.60%
  • 5

    Chugai Pharmaceutical Co. Ltd. Com Stk

    4519:JPUnknown
    6.54%
  • 6

    Shionogi & Co Ltd

    4507:JPUnknown
    5.90%
  • 7

    Merck & Company Inc

    MRKHealth Care
    5.71%
  • 8

    Roche Holding Ag

    ROG:SMUnknown
    5.54%
  • 9

    Pfizer, Inc.

    PFEHealth Care
    4.97%
  • 10

    Developed Markets Astrazeneca Plc Sponsored Adr

    AZN:LNHealth Care
    4.96%
  • 11

    Abbvie Inc

    ABBVHealth Care
    4.62%
  • 12

    Innovent Biologics Inc

    1801:HKHealth Care
    4.44%
  • 13

    CSPC Pharmaceutical Group Limited Shs

    1093:HKHealth Care
    4.27%
  • 14

    Arrowhead Pharmaceuticals Inc

    ARWRHealth Care
    3.96%
  • 15

    Hims & Hers Health Inc

    HIMSHealth Care
    2.30%
  • 16

    Zealand Pharma As

    ZEAL:COUnknown
    1.99%
  • 17

    Scholar Rock Holding Corp

    SRRKHealth Care
    1.71%
  • 18

    Viking Therapeutics, Inc.

    VKTXHealth Care
    1.50%
  • 19

    Hanmi Pharm Co Ltd

    128940:KRUnknown
    1.04%
  • 20

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    0.88%
  • 21

    Jiangsu Hengrui Pharmaceutic

    600276:SHUnknown
    0.85%
  • 22

    Cash & Other

    Other
    0.58%